Page last updated: 2024-10-20

urea and Myasthenia Gravis

urea has been researched along with Myasthenia Gravis in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LASSEN, HC1

Other Studies

1 other study available for urea and Myasthenia Gravis

ArticleYear
HYPOVENTILATION IN PATIENTS WITH NORMAL LUNGS, POLIOMYELITIS, MYASTHENIA GRAVIS, BARBITURATE POISONING, ETC.
    Annals of the New York Academy of Sciences, 1965, Mar-24, Volume: 121

    Topics: Barbiturates; Botulism; Bronchitis; Denmark; Diuresis; Humans; Hypoventilation; Intubation; Intubati

1965